Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Molecular Diagnosis and Therapy Market by Type (PCR, DNA Sequencing, NGS), By Application (Diagnostic Laboratories, Research & Academic Laboratories) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Molecular Diagnosis and Therapy Market by Type (PCR, DNA Sequencing, NGS), By Application (Diagnostic Laboratories, Research & Academic Laboratories) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 168359 3300 Medical Devices & Consumables 377 243 Pages 4.9 (35)
                                          

The global molecular diagnosis and therapy market is expected to grow at a CAGR of 8.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases, rising demand for personalized medicine, and technological advancements in the field of molecular diagnostics. PCR segment accounted for the largest share in the global molecular diagnosis and therapy market in 2018. PCR segment is expected to maintain its dominance throughout the forecast period due to its wide range of applications across various industries such as clinical laboratories, research & academic laboratories, hospitals & clinics, pharmaceuticals & biotechnology companies etc, which are driving growth in this segment. NGS segment accounted for a small share in 2018 but it is expected that it will grow at a CAGR of 10% during the forecast period owing to its high accuracy rate and wide range of applications across various industries such as clinical laboratories etc, which are driving growth in this segment.

Some Of The Growth Factors Of This Market:

  1. Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is driving the growth of the molecular diagnosis and therapy market.
  2. Increasing government funding for research in this field is also driving the growth of the molecular diagnosis and therapy market.
  3. The increasing number of mergers & acquisitions in this field is also driving the growth of the molecular diagnosis and therapy market.
  4. The increasing demand for personalized medicine.

Industry Growth Insights published a new data on “Molecular Diagnosis and Therapy Market”. The research report is titled “Molecular Diagnosis and Therapy Market research by Types (PCR, DNA Sequencing, NGS), By Applications (Diagnostic Laboratories, Research & Academic Laboratories), By Players/Companies Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biomérieux Sa, Danaher Corporation, Diasorin, Grifols, Hologic, Illumina, Qiagen, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Molecular Diagnosis and Therapy Market Research Report

By Type

PCR, DNA Sequencing, NGS

By Application

Diagnostic Laboratories, Research & Academic Laboratories

By Companies

Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Biomérieux Sa, Danaher Corporation, Diasorin, Grifols, Hologic, Illumina, Qiagen, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

243

Number of Tables & Figures

171

Customization Available

Yes, the report can be customized as per your need.


Global Molecular Diagnosis and Therapy Industry Outlook


Global Molecular Diagnosis and Therapy Market Report Segments:

The global Molecular Diagnosis and Therapy market is segmented on the basis of:

Types

PCR, DNA Sequencing, NGS

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Diagnostic Laboratories, Research & Academic Laboratories

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abbott Laboratories
  2. Agilent Technologies
  3. Becton, Dickinson and Company
  4. Biomérieux Sa
  5. Danaher Corporation
  6. Diasorin
  7. Grifols
  8. Hologic
  9. Illumina
  10. Qiagen
  11. Roche Diagnostics
  12. Siemens AG
  13. Thermo Fisher Scientific

Global Molecular Diagnosis and Therapy Market Overview


Highlights of The Molecular Diagnosis and Therapy Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. PCR
    2. DNA Sequencing
    3. NGS
  1. By Application:

    1. Diagnostic Laboratories
    2. Research & Academic Laboratories
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Molecular Diagnosis and Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Molecular Diagnosis and Therapy Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Molecular diagnostics and therapy is the application of molecular biology, genetics, and other scientific disciplines to diagnose and treat diseases. Molecular diagnostics can identify specific genes or proteins that are abnormal in a patient's body. Therapeutic interventions may then be directed at correcting these abnormalities.

Some of the major companies in the molecular diagnosis and therapy market are Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, BiomƒÂ©rieux Sa, Danaher Corporation, Diasorin, Grifols, Hologic, Illumina, Qiagen, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific.

The molecular diagnosis and therapy market is expected to grow at a compound annual growth rate of 8.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Molecular Diagnosis and Therapy Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Molecular Diagnosis and Therapy Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Molecular Diagnosis and Therapy Market - Supply Chain
   4.5. Global Molecular Diagnosis and Therapy Market Forecast
      4.5.1. Molecular Diagnosis and Therapy Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Molecular Diagnosis and Therapy Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Molecular Diagnosis and Therapy Market Absolute $ Opportunity

5. Global Molecular Diagnosis and Therapy Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Molecular Diagnosis and Therapy Market Size and Volume Forecast by Type
      5.3.1. PCR
      5.3.2. DNA Sequencing
      5.3.3. NGS
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Molecular Diagnosis and Therapy Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Molecular Diagnosis and Therapy Market Size and Volume Forecast by Application
      6.3.1. Diagnostic Laboratories
      6.3.2. Research & Academic Laboratories
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Molecular Diagnosis and Therapy Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Molecular Diagnosis and Therapy Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Molecular Diagnosis and Therapy Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Molecular Diagnosis and Therapy Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Molecular Diagnosis and Therapy Demand Share Forecast, 2019-2026

9. North America Molecular Diagnosis and Therapy Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Molecular Diagnosis and Therapy Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Molecular Diagnosis and Therapy Market Size and Volume Forecast by Application
      9.4.1. Diagnostic Laboratories
      9.4.2. Research & Academic Laboratories
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Molecular Diagnosis and Therapy Market Size and Volume Forecast by Type
      9.7.1. PCR
      9.7.2. DNA Sequencing
      9.7.3. NGS
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Molecular Diagnosis and Therapy Demand Share Forecast, 2019-2026

10. Latin America Molecular Diagnosis and Therapy Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Molecular Diagnosis and Therapy Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Molecular Diagnosis and Therapy Market Size and Volume Forecast by Application
      10.4.1. Diagnostic Laboratories
      10.4.2. Research & Academic Laboratories
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Molecular Diagnosis and Therapy Market Size and Volume Forecast by Type
      10.7.1. PCR
      10.7.2. DNA Sequencing
      10.7.3. NGS
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Molecular Diagnosis and Therapy Demand Share Forecast, 2019-2026

11. Europe Molecular Diagnosis and Therapy Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Molecular Diagnosis and Therapy Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Molecular Diagnosis and Therapy Market Size and Volume Forecast by Application
      11.4.1. Diagnostic Laboratories
      11.4.2. Research & Academic Laboratories
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Molecular Diagnosis and Therapy Market Size and Volume Forecast by Type
      11.7.1. PCR
      11.7.2. DNA Sequencing
      11.7.3. NGS
   11.8. Basis Point hare (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Molecular Diagnosis and Therapy Demand Share, 2019-2026

12. Asia Pacific Molecular Diagnosis and Therapy Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Molecular Diagnosis and Therapy Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Molecular Diagnosis and Therapy Market Size and Volume Forecast by Application
      12.4.1. Diagnostic Laboratories
      12.4.2. Research & Academic Laboratories
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Molecular Diagnosis and Therapy Market Size and Volume Forecast by Type
      12.7.1. PCR
      12.7.2. DNA Sequencing
      12.7.3. NGS
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Molecular Diagnosis and Therapy Demand Share, 2019-2026

13. Middle East & Africa Molecular Diagnosis and Therapy Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Molecular Diagnosis and Therapy Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Molecular Diagnosis and Therapy Market Size and Volume Forecast by Application
      13.4.1. Diagnostic Laboratories
      13.4.2. Research & Academic Laboratories
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Molecular Diagnosis and Therapy Market Size and Volume Forecast by Type
      13.7.1. PCR
      13.7.2. DNA Sequencing
      13.7.3. NGS
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Molecular Diagnosis and Therapy Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Molecular Diagnosis and Therapy Market: Market Share Analysis
   14.2. Molecular Diagnosis and Therapy Distributors and Customers
   14.3. Molecular Diagnosis and Therapy Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Abbott Laboratories
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Agilent Technologies
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Becton, Dickinson and Company
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Biomérieux Sa
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Danaher Corporation
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Diasorin
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Grifols
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Hologic
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Illumina
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Qiagen
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Roche Diagnostics
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Siemens AG
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Thermo Fisher Scientific
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us